Surveys / Trackers / ATUs

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

A startup wanted to understand how customers could use its cutting-edge technology and which applications to target for further development

An early-stage venture firm requested a high-level commercial due diligence of a potential investment

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market